0001628280-24-001196.txt : 20240111
0001628280-24-001196.hdr.sgml : 20240111
20240111171230
ACCESSION NUMBER: 0001628280-24-001196
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240109
FILED AS OF DATE: 20240111
DATE AS OF CHANGE: 20240111
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Nouri Alaleh
CENTRAL INDEX KEY: 0001599418
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40797
FILM NUMBER: 24529945
MAIL ADDRESS:
STREET 1: 1310 CHESAPEAKE TERRACE
CITY: SUNNYVALE
STATE: CA
ZIP: 94089
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: PROCEPT BioRobotics Corp
CENTRAL INDEX KEY: 0001588978
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
ORGANIZATION NAME: 08 Industrial Applications and Services
IRS NUMBER: 260199180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
BUSINESS PHONE: 650-232-7200
MAIL ADDRESS:
STREET 1: 900 ISLAND DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94065
4
1
wk-form4_1705011139.xml
FORM 4
X0508
4
2024-01-09
0
0001588978
PROCEPT BioRobotics Corp
PRCT
0001599418
Nouri Alaleh
C/O PROCEPT BIOROBOTICS CORPORATION
150 BAYTECH DRIVE
SAN JOSE
CA
95134
0
1
0
0
EVP, CLO, CORP. SEC.
1
Common Stock
2024-01-09
4
M
0
16000
4.56
A
63351
D
Common Stock
2024-01-09
4
S
0
16000
44.9672
D
47351
D
Stock Option (Right to Buy)
4.56
2024-01-09
4
M
0
16000
0
D
2029-12-12
Common Stock
16000
13697
D
All transactions reported here were effected pursuant to a Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023.
Includes 418 shares acquired on May 12, 2023 under the Issuer's 2021 Employee Stock Purchase Plan.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $44.95 to $45.15, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.
The Stock option was granted on December 12, 2019 and vested over a four year period.
/s/ Jonathan Stone, Attorney-in-Fact for Alaleh Nouri
2024-01-11